Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Qsymia More Cost-Effective Weight Loss Treatment for Children Than Ozempic, Wegovy: Study The cost of Ozempic, Wegovy and other similar diet drugs often exceeded most people’s “willingness-to-pay” price point for the weight loss benefits they provided, researchers noted. October 20, 2023 Irvin Jackson Add Your Comments Amid increasing media attention and marketing for a new generation of antiobesity drugs, such as Ozempic and Wegovy, a new study indicates that Qsymia may be a more cost-effective weight loss solution, at least for children. Canadian researchers report that even though semaglutide, the active ingredient in Ozempic and Wegovy, can lead to greater weight loss for obese children, when they looked at the cost effectiveness, they found that Qsymia was more affordable, while the cost of semaglutide-based drugs often exceeded a “willingness to pay” threshold used by medical experts to predict consumer reactions. Their findings were published on October 12 in JAMA Network Open. The American Academy of Pediatrics has recommended that adolescents with severe obesity be treated with weight loss medications, but there is little information available to them about which drugs are safest and most effective. Qsymia was approved by the FDA in 2012, involving a combination of phentermine, an amphetamine, and topiramate, an antiseizure drug used in Topamax. Phentermine was the “Phen” in Fen Phen, which was recalled due to heart problems, and topiramate side effects have been linked to women having babies with cleft palate and cleft lip birth defects. Ozempic, which was originally approved for the treatment of Type 2 diabetes, has been increasingly prescribed for weight loss, which is considered an “off-label” prescription. However, the higher-dose version, Wegovy, is approved specifically for weight loss, even though the two drugs use the same active ingredient. A similar drug, Mounjaro, was approved last year. Although the drugs have been marketed as safe and effective, concerns have emerged in recent months about painful and debilitating gastrointestinal problems, primarily involving a medical condition known as gastroparesis, or stomach paralysis, which results in delayed emptying of the stomach. As a result of the drug maker’s failure to sufficiently disclose the risk, a number of former users are now pursuing Ozempic lawsuits and Wegovy lawsuits, each raising similar allegations that they developed painful and debilitating stomach problems, which could have been avoided if false and misleading information had not been provided for users and the medical community. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION In this latest study, researchers put aside the health risks and focused on conducting an economic evaluation which compared Qsymia (phentermine-topiramate) with Ozempic and Wegovy, as well as Xenical, Alli and Victoza. The researchers measured the effectiveness by looking at quality-adjusted life-years (QALYs) and costs estimated in 2023 U.S. dollars over 10 years. Among the four drugs approved for pediatric weight loss, Qsymia, semaglutide drugs like Ozempic and Wegovy, Xenical and Alli (orlistat) and Victoza (liraglutide), Qsymia was the most cost effective, the researchers determined. While the semaglutide drugs led to more QALYs than Qsymia, there was a significant cost difference. Treatment with Ozempic and similar drugs cost $1, 079,480 per quality of life years, while Qsymia cost only $93,620 in comparison. Researchers noted that the commonly used willingness-to-pay threshold for a drug threshold for consumers is between $100,000 and $150,000 per QALY. Orlistat-based drugs and Victoza were not as effective as either Ozempic or Qsymia, the researchers determined. “In this economic evaluation of weight loss drugs for adolescents with severe obesity, we found phentermine-topiramate to be a cost-effective treatment at a willingness-to-pay threshold of $100 000 to $150 000/QALY,” the researchers concluded. “Further research is needed to determine long-term drug efficacy and how long adolescents continue treatment.” Ozempic, Wegovy Stomach Paralysis Risks While this latest study did not focus on the safety aspect of the weight loss drugs, it comes just weeks after the U.S. Food and Drug Administration (FDA) issued new label warnings for Ozempic, indicating that it can increase the risk of intestinal blockages. The warning links Ozempic to a condition known as ileus, which can cause abdominal cramps, bloating, nausea, vomiting, constipation, difficulty passing gas and difficulty eating. The symptoms of gastroparesis and pancreatitis from Ozempic are similar to ileus, including nausea, vomiting undigested food, abdominal pain, abdominal bloating, severe dehydration, feeling full after only a few bites, undigested food hardening in the stomach, acid reflux, fluctuating blood sugar levels, lack of appetite, weight loss, malnutrition and decreased quality of life. However, some users diagnosed with Ozempic-induced gastroparesis report that the side effects persisted long after the drug is discontinued. In July, a CNN investigation outlined an alarming number of reports linking Ozempic and gastroparesis, indicating that similar problems have been associated with other drugs in the same class in recent years. In 2017, researchers with the Mayo Clinic conducted a study involving Victoza, which found that the drug caused significantly slower digestion in users, taking about 70 minutes for half the food they ate to leave their stomachs, compared to four minutes for people who did not take the drug. However, the study found that people’s bodies tended to adjust over time. It is widely expected that or thousands of claims over Ozempic stomach paralysis may be brought in the coming months and years, as well as Wegovy lawsuits and Mounjaro lawsuits over similar gastrointestinal risks associated with these similar medications. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Alli, Children, Gastroparesis, Mounjaro, Obesity, Ozempic, Qysmia, Stomach Paralysis, Victoza, Wegovy, Weight Loss, Xenical Find Out If You Qualify for Ozempic or Wegovy Compensation More Ozempic, Wegovy and Mounjaro Lawsuit Stories Ozempic, Wegovy Kidney Side Effects Highlighted in New Study October 10, 2025 Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue October 7, 2025 Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s October 3, 2025 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: yesterday) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. As complication reports rise and more women undergo revision surgery, lawsuits are now being investigated against companies that promoted mesh for off-label breast procedures despite FDA warnings and no breast-specific safety data. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) With Roblox Being Sued by Families Nationwide, JPML To Consider Centralizing Claims (Posted: 2 days ago) A panel of federal judges will decide in December whether to consolidate all claims brought by parents who allege that Roblox facilitated child sexual exploitation into a multidistrict litigation. MORE ABOUT: ROBLOX LAWSUITInternet Gaming Disorder May Affect 1 in 10 Adolescent Boys: Study (10/15/2025)Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (10/10/2025)Roblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025) MDL Judge Calls for New Census of Suboxone Tooth Decay Lawsuits (Posted: 3 days ago) A federal judge has called for a second census of Suboxone tooth decay lawsuits and will require prompt filing of census forms for claims filed from October 1 forward. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITTramadol Side Effects Outweigh Pain Management Benefits, Study Finds (10/15/2025)Gabapentin Use Increasing Along With Abuse Concerns: Report (10/09/2025)Gabapentin Prescriptions Could Be Leading to Growing Abuse Epidemic: Study (09/17/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue October 7, 2025
Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s October 3, 2025
Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: yesterday) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. As complication reports rise and more women undergo revision surgery, lawsuits are now being investigated against companies that promoted mesh for off-label breast procedures despite FDA warnings and no breast-specific safety data. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
With Roblox Being Sued by Families Nationwide, JPML To Consider Centralizing Claims (Posted: 2 days ago) A panel of federal judges will decide in December whether to consolidate all claims brought by parents who allege that Roblox facilitated child sexual exploitation into a multidistrict litigation. MORE ABOUT: ROBLOX LAWSUITInternet Gaming Disorder May Affect 1 in 10 Adolescent Boys: Study (10/15/2025)Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (10/10/2025)Roblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)
MDL Judge Calls for New Census of Suboxone Tooth Decay Lawsuits (Posted: 3 days ago) A federal judge has called for a second census of Suboxone tooth decay lawsuits and will require prompt filing of census forms for claims filed from October 1 forward. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITTramadol Side Effects Outweigh Pain Management Benefits, Study Finds (10/15/2025)Gabapentin Use Increasing Along With Abuse Concerns: Report (10/09/2025)Gabapentin Prescriptions Could Be Leading to Growing Abuse Epidemic: Study (09/17/2025)